Literature DB >> 20528931

Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.

Viviana Cafiso1, Taschia Bertuccio, Daniela Spina, Simona Purrello, Stefania Stefani.   

Abstract

The purpose of our study was to evaluate the anti-staphylococcal biofilm activity of tigecycline, compared with a group of recently developed or commonly used antimicrobials such as linezolid, daptomycin, levofloxacin, tobramycin and rifampin, all possessing putative antibiofilm properties, on a sample of multi-drug-resistant methicillin-resistant Staphylococcus aureus grown as a planktonic and mature biofilm. We determined conventional minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for the planktonic forms, MICs of adherent cells and finally, minimum biofilm eradication concentrations (MBECs). No drug was able to inhibit adherent bacteria at the same concentration necessary for eradicating a mature biofilm; the latter concentrations varied from three to seven times higher than the ones inhibiting adhesion. The concentrations eradicating biofilm were reached by rifampin and daptomycin at lower concentrations with respect to the other antibiotics tested; tigecycline was able to inhibit mature biofilms at higher concentrations, while all the other antibiotics were only able to inhibit adhering cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528931     DOI: 10.1111/j.1574-695X.2010.00701.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

1.  Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection.

Authors:  F Bartalesi; S Veloci; F Baragli; E Mantengoli; S Guidi; A M Bartolesi; R Mannino; P Pecile; A Bartoloni
Journal:  Infection       Date:  2011-10-18       Impact factor: 3.553

2.  Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.

Authors:  Jared A Niska; Jonathan H Shahbazian; Romela Irene Ramos; Jonathan R Pribaz; Fabrizio Billi; Kevin P Francis; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

3.  In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.

Authors:  Alexandra I Stavrakis; Suwei Zhu; Vishal Hegde; Amanda H Loftin; Alyssa G Ashbaugh; Jared A Niska; Lloyd S Miller; Tatiana Segura; Nicholas M Bernthal
Journal:  J Bone Joint Surg Am       Date:  2016-07-20       Impact factor: 5.284

4.  A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.

Authors:  Julia Bauer; Wafi Siala; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

5.  Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management.

Authors:  Chiara Pascolini; Jolinda Sinagra; Simone Pecetta; Valentina Bordignon; Alessandra De Santis; Laura Cilli; Viviana Cafiso; Grazia Prignano; Bruno Capitanio; Claudio Passariello; Stefania Stefani; Paola Cordiali-Fei; Fabrizio Ensoli
Journal:  Clin Dev Immunol       Date:  2011-10-27

6.  Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.

Authors:  John M Thompson; Vikram Saini; Alyssa G Ashbaugh; Robert J Miller; Alvaro A Ordonez; Roger V Ortines; Yu Wang; Robert S Sterling; Sanjay K Jain; Lloyd S Miller
Journal:  J Bone Joint Surg Am       Date:  2017-04-19       Impact factor: 5.284

7.  Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model.

Authors:  A I Stavrakis; S Zhu; A H Loftin; X Weixian; J Niska; V Hegde; T Segura; N M Bernthal
Journal:  Biomed Res Int       Date:  2019-12-12       Impact factor: 3.411

Review 8.  Biofilm Formation by Pathogenic Bacteria: Applying a Staphylococcus aureus Model to Appraise Potential Targets for Therapeutic Intervention.

Authors:  Zahra Sedarat; Andrew W Taylor-Robinson
Journal:  Pathogens       Date:  2022-03-23

9.  Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.

Authors:  Francesca Sivori; Ilaria Cavallo; Daniela Kovacs; Maria Guembe; Isabella Sperduti; Mauro Truglio; Martina Pasqua; Grazia Prignano; Arianna Mastrofrancesco; Luigi Toma; Fulvia Pimpinelli; Aldo Morrone; Fabrizio Ensoli; Enea Gino Di Domenico
Journal:  Microbiol Spectr       Date:  2022-04-13

10.  Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.

Authors:  Carla Mottola; Carina S Matias; João J Mendes; José Melo-Cristino; Luís Tavares; Patrícia Cavaco-Silva; Manuela Oliveira
Journal:  BMC Microbiol       Date:  2016-06-23       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.